Analysen von James Gordon
| 25.10.23 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 24.10.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.10.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.10.23 | Sandoz Overweight | JP Morgan Chase & Co. | |
| 29.09.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 22.09.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 18.09.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 11.09.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 08.09.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.08.23 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 10.08.23 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 08.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.07.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 28.07.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.07.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.07.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.07.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 10.07.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.07.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.07.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.06.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 23.06.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 22.06.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 21.06.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 16.06.23 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 14.06.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.06.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.05.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 17.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.05.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.05.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 04.05.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 02.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.04.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 11.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.04.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 24.03.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 17.03.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 16.03.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 10.03.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |